Gene · 53345
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD). | EXCLI J | 2023 | 38023570 | PubTator, text mining | PubMed |
| Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma. | Transl Gastroenterol Hepatol | 2023 | 38021355 | PubTator, text mining | PubMed |
| Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study. | BMC Med | 2023 | 38017422 | PubTator, text mining | PubMed |
| From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention. | Cancers (Basel) | 2023 | 38001718 | PubTator, text mining | PubMed |
| Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease. | Metabolites | 2023 | 37999211 | PubTator, text mining | PubMed |
| Molecular Aspects of MAFLD-New Insights on Pathogenesis and Treatment. | Curr Issues Mol Biol | 2023 | 37998750 | PubTator, text mining | PubMed |
| Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations. | Atherosclerosis | 2023 | 37989062 | PubTator, text mining | PubMed |
| Modeling Liver Development and Disease in a Dish. | Int J Mol Sci | 2023 | 37958904 | PubTator, text mining | PubMed |
| Mechanisms of liver fibrosis in metabolic syndrome. | eGastroenterology | 2023 | 37946713 | PubTator, text mining | PubMed |
| The association between telomere length and non-alcoholic fatty liver disease: a prospective study. | BMC Med | 2023 | 37940980 | PubTator, text mining | PubMed |
| The Impact and Burden of Dietary Sugars on the Liver. | Hepatol Commun | 2023 | 37930128 | PubTator, text mining | PubMed |
| Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease. | Lipids Health Dis | 2023 | 37924128 | PubTator, text mining | PubMed |
| TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease. | Hepatol Forum | 2023 | 37920782 | PubTator, text mining | PubMed |
| Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults. | BMC Gastroenterol | 2023 | 37919650 | PubTator, text mining | PubMed |
| Genome-wide association analysis of plasma lipidome identifies 495 genetic associations. | Nat Commun | 2023 | 37907536 | PubTator, text mining | PubMed |
| Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment. | Diabetes Metab Syndr Obes | 2023 | 37905232 | PubTator, text mining | PubMed |
| An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. | Nat Med | 2023 | 37903863 | PubTator, text mining | PubMed |
| Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics. | Biomedicines | 2023 | 37893185 | PubTator, text mining | PubMed |
| Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors. | Biomedicines | 2023 | 37893134 | PubTator, text mining | PubMed |
| Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter 2 Inhibitor Therapy. | J Clin Med | 2023 | 37892698 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53345/papers?page=13